cenobamate
Commercial- Indications
- focal seizures
Company intelligence / Profile preview
Paladin Labs Inc. operates as a specialty pharmaceutical company focused on acquiring or in‐licensing innovative pharmaceutical products for the Canadian market. The company has over sixty marketed drugs across multiple therapeutic areas such as urology, oncology/pain management, endocrinology/diabetes care, allergy/immunotherapy, women’s health/contraception, dermatology and neurology/CNS. It was acquired by Endo International plc in February of 2014 but continues to operate under its own brand with commercial operations primarily in Canada.[5]
5 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Paladin Labs Inc..